Loading compound...
Tubulin inhibitor
Plinabulin is a small molecule drug that works by inhibiting tubulin, which is a protein involved in cell division. It is currently being studied in clinical trials for various types of cancer, including non-small cell lung carcinoma and multiple myeloma.
How it worksPlinabulin stops cancer cells from dividing by targeting and blocking tubulin.
Used for
Non-small cell lung carcinomaMultiple myelomaSmall cell lung carcinomaCancer
Conditions
Non-small cell lung carcinomaMultiple myelomaSmall cell lung carcinomaCancer
Class
Tubulin inhibitorSmall moleculeImmune system (neutropenia risk)Cancerous cells
How to take
Plinabulin is currently in clinical development phases (up to Phase 3) and is not yet widely available for general use.
Side effects
Serious
- ·Neutropenia (low white blood cell count)
Talk to your doctor
Monitor
- ·White blood cell counts (neutropenia)
Questions to ask
- ·Is Plinabulin appropriate for my type of cancer?
- ·What are the risks of neutropenia with this medication?
- ·What stage of clinical trials is Plinabulin currently in?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
